Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Patent
1989-01-09
1991-07-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
A61K 3342
Patent
active
050284398
ABSTRACT:
Parathyroid Hormone, when excessively synthesized, induces pathologic bone resorption and demineralization and results in hypocalcemia which produces toxic effects in soft tissues. Non-toxic water-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid, administered orally or systemically, inhibits parathyroid hormone induced bone resorption in vitro and in vivo in warm blooded animals.
REFERENCES:
patent: 4041149 (1977-08-01), Gaffar
patent: 4177258 (1979-12-01), Gaffar et al.
patent: 4183915 (1980-01-01), Gaffar et al.
patent: 4273759 (1981-06-01), Gaffar et al.
patent: 4309410 (1982-01-01), Gaffar
patent: 4430325 (1984-02-01), Gaffar et al.
patent: 4431631 (1984-02-01), Clipper et al.
patent: 4537765 (1985-08-01), Gaffar et al.
patent: 4537778 (1985-08-01), Clipper et al.
patent: 4547361 (1985-10-01), Steltenkamp et al.
Textbook of Medicine, 16th Ed. (1982) p. 1336; Cecil.
Colgate - Palmolive Company
Grill Murray M.
Henley III Raymond J.
Stone Robert L.
Waddell Frederick E.
LandOfFree
Inhibition of parathyroid hormone secretion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of parathyroid hormone secretion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of parathyroid hormone secretion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245671